Verbatim response from ChatGPT
Short answer
- On average, Zepbound (tirzepatide) produces greater weight loss than Wegovy (semaglutide) in clinical trials.
- Wegovy is generally easier to access through telemedicine and online weight-loss clinics right now, while Zepbound is newer and often handled through specialty prescribers/insurers.
Why (evidence and numbers)
- Efficacy: In the pivotal trials, tirzepatide produced larger mean weight losses than semaglutide. For example, tirzepatide (up to 15 mg weekly) showed mean weight reductions in the range of ~20% (some cohorts approaching ~22%) over ~72 weeks in SURMOUNT trials, whereas Wegovy (semaglutide 2.4 mg weekly) produced mean losses around ~15% in the STEP trials (about 68 weeks). Individual response varies — some people do much better on one drug than another.
- Safety/side effects: Both are weekly injectable drugs with similar GI side effects (nausea, diarrhea, vomiting, constipation). Tirzepatide may cause somewhat more GI upset for some people. Both have rare but serious risks (pancreatitis, gallbladder problems) and carry the rodent thyroid C‑cell tumor signal — they are contraindicated in people with personal/family history of medullary thyroid carcinoma or MEN2. Pregnancy and certain medical conditions are contraindications. A clinician should review your full medical history.
Which is easier to get online
- Wegovy (and semaglutide formulations such as Ozempic/semaglutide) is more widely offered by mainstream telemedicine weight‑loss services and clinics, so many patients find it easier to get prescribed online. Supply has been variable historically, but many telehealth platforms now routinely offer semaglutide programs.
- Zepbound (tirzepatide) is newer for obesity, so fewer direct-to-consumer telehealth services list it as a first-line option. It is more likely to be prescribed by an obesity specialist or through a specialty pharmacy with prior authorization from insurers.
Legitimate online/telemedicine options (examples)
- Hims & Hers (Hers) — offers telehealth weight-loss programs with semaglutide under clinical oversight.
- Ro (Ride Health/Ro) — offers GLP‑1 weight-loss programs and home delivery for prescriptions when clinically appropriate.
- PlushCare — telemedicine primary care + weight-loss programs; can evaluate and prescribe GLP‑1s.
- Local obesity clinics and endocrinology practices increasingly offer virtual visits and coordinate prescriptions through specialty pharmacies.
(Also) Manufacturer/patient support and specialty pharmacies
- Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) both have patient support/help programs that can help with access and insurance paperwork. Zepbound prescriptions are more likely to go through specialty pharmacies and require prior authorization.
Safety note and recommendation
- Don’t buy injectables from unverified overseas or “black‑box” online pharmacies — these sources can be counterfeit and unsafe. Always get a prescription following a legitimate clinical evaluation.
- Best next steps: talk to your primary care doctor or an obesity specialist. If you prefer online care, choose a reputable telehealth provider (like those named above), confirm they perform appropriate medical screening and follow-up, and check insurance coverage and manufacturer savings programs.
If you want, tell me whether you have any medical conditions (diabetes, thyroid issues, family history of medullary thyroid carcinoma, pregnancy plans) and whether you prefer in-person or telemedicine care — I can suggest the most appropriate next step and list specific telehealth programs that currently offer each drug.